Æterna Zentaris A részvények lebegnek
Mi az Æterna Zentaris A részvények lebegnek?
A A részvények lebegnek az Æterna Zentaris, Inc. - 4.844M 99.75%
Mi a A részvények lebegnek meghatározása?
Részvények úszó az a része, a vállalat részvényeinek, hogy a kezében az állami befektetők, szemben a bezárt raktáron.
Shares float represents the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock held by promoters, company officers, controlling-interest investors, or government. This number is sometimes seen as a better way of calculating market capitalization because it provides a more accurate reflection of what public investors consider the company to be worth. In this context, the float may refer to all the shares outstanding that can be publicly traded
The float is calculated by subtracting the locked-in shares from outstanding shares. Stocks with smaller floats tend to be more volatile than those with larger floats. In general, the large holdings of founding shareholders, corporate cross-holdings, and government holdings in partially privatized companies are excluded when calculating the size of a public float.
A részvények lebegnek a Health Care szektor a TSX-on cégekben a Æterna Zentaris -hoz képest
Mit csinál Æterna Zentaris?
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as oncology indications. The company markets macimorelin under the Macrilen brand name. Aeterna Zentaris Inc. has a license agreement with University Wuerzburg to research, develop, manufacture, and sell a potential COVID-19 vaccine; development, manufacture, and commercialization of the treatment for neuromyelitis optica spectrum disorder; and to develop human 3D intestinal tissue models to study infection biology; and for pre-clinical development towards the potential treatment of Parkinson's disease. It also has a license agreement with Consilient Health Ltd., Novo Nordisk Novo Nordisk Health Care AG, and NK MEDITECH Ltd. for the development and commercialization of macimorelin in the United States and Canada, as well as The University of Sheffield, the United Kingdom for the research, development, manufacture, and commercialization of parathyroid hormone fusion polypeptides for the treatment of primary hypoparathyroidism. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina.
a részvények lebegnek -hoz hasonló cégek Æterna Zentaris
- Technofab Engineering nak A részvények lebegnek 4.824M 45.99% van
- Jash Engineering nak A részvények lebegnek 4.824M 40.76% van
- Esports Entertainment nak A részvények lebegnek 4.826M van
- Bal Pharma nak A részvények lebegnek 4.834M 34.11% van
- Pinetree Capital nak A részvények lebegnek 4.836M 51.52% van
- Kina Petroleum nak A részvények lebegnek 4.842M 37.77% van
- Æterna Zentaris nak A részvények lebegnek 4.844M 99.75% van
- FFP Societe anonyme nak A részvények lebegnek 4.847M 19.55% van
- Bisichi PLC nak A részvények lebegnek 4.847M 45.40% van
- Novotek AB nak A részvények lebegnek 4.854M van
- FP Newspapers nak A részvények lebegnek 4.860M 70.41% van
- SES-imagotag SA nak A részvények lebegnek 4.866M 30.89% van
- Kaya nak A részvények lebegnek 4.868M 37.26% van